Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012355 |
---|---|
Receipt number | R000014445 |
Scientific Title | Treatment of the genetic defect of cholesterol biosynthetic pathway by the topical application of statin and cholesterol |
Date of disclosure of the study information | 2013/11/19 |
Last modified on | 2021/11/24 16:55:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/11/19 23:15:39 | ||
2 | Update | 2013/12/09 14:48:44 | Condition Condition |
|
3 | Update | 2014/02/23 19:50:20 | Anticipated trial start date |
|
4 | Update | 2014/11/19 10:20:32 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2015/05/19 12:48:17 | Interventions/Control_1 Interventions/Control_1 |
|
6 | Update | 2015/05/19 12:48:34 | ||
7 | Update | 2016/11/20 18:17:13 | Name of primary person or sponsor Organization |
|
8 | Update | 2016/11/20 18:20:26 | Interventions/Control_1 |
|
9 | Update | 2018/11/22 09:12:23 | Condition Condition |
|
10 | Update | 2018/11/22 09:13:25 | Condition Condition |
|
11 | Update | 2018/11/22 09:19:08 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria Target sample size |
|
12 | Update | 2019/12/23 09:00:35 | Recruitment status Date of IRB Last follow-up date |
|
13 | Update | 2019/12/23 09:01:06 | Number of participants that the trial has enrolled |
|
14 | Update | 2019/12/23 09:04:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
15 | Update | 2020/05/25 08:55:21 | Last follow-up date |
|
16 | Update | 2020/05/25 09:03:20 | ||
17 | Update | 2020/11/24 09:45:24 | Number of participants that the trial has enrolled Results Adverse events |
|
18 | Update | 2021/11/24 16:55:30 | Recruitment status |